12-09-2026 11:00 via prnewswire.com

Nocpix Launches ACE 2: The Next Generation of Its Flagship Thermal Riflescope

WARSAW, Poland, Sept. 12, 2026 /PRNewswire/ -- On Sept. 12, Nocpix officially launched the ACE 2 Series, its next-generation flagship thermal riflescope lineup, including the ACE 2 S60R, ACE 2 H50R, and ACE 2 H35R. Building on the foundation of the original ACE, ACE 2 advances the...
Read more »

PR Public relations news



POWTEK Group, Heating Tech Expo 2026 ve Zuchex 2026 Fuarlarında Çok Markalı Üretim Gücünü Sergiliyor
POWTEK Group, Heating Tech Expo 2026 ve Zuchex 2026 Fuarlarında Çok Markalı Üretim Gücünü Sergiliyor
CARNIVAL TROPICALE 現已開放預訂,將於 2028 年自加爾維斯敦啟航
CARNIVAL TROPICALE 現已開放預訂,將於 2028 年自加爾維斯敦啟航
Aignostics bringt „PathoSearch" auf den Markt, eine visuelle Suchmaschine für pathologische Fälle
Aignostics bringt „PathoSearch" auf den Markt, eine visuelle Suchmaschine für pathologische Fälle
CARNIVAL TROPICALE 号开放预订 | CARNIVAL TROPICALE 号正式开放预订,2028 年将从加尔维斯顿启航
CARNIVAL TROPICALE 号开放预订 | CARNIVAL TROPICALE 号正式开放预订,2028 年将从加尔维斯顿启航
Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques
Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques
PwC US and PwC India Form Joint Venture to Help Clients Grow and Compete at Greater Speed and Scale
PwC US and PwC India Form Joint Venture to Help Clients Grow and Compete at Greater Speed and Scale
SURF'S UP FOR THE WORLD'S PAW-SOME-EST COMPETITORS!
SURF'S UP FOR THE WORLD'S PAW-SOME-EST COMPETITORS!
Quantinuum participará en la 5ª Conferencia anual Growth Frontiers de Piper Sandler
Quantinuum participará en la 5ª Conferencia anual Growth Frontiers de Piper Sandler
CGTN: Jak BRICS vytváří nové příležitosti pro rozvoj Globálního Jihu
CGTN -- Как БРИКС создает новые возможности для развития Глобального Юга
CGTN: Ako BRICS vytvára nové príležitosti pre rozvoj globálneho Juhu
CGTN : Comment les BRICS ouvrent de nouvelles perspectives pour le développement des pays du Sud
CGTN: Wie die BRICS-Staaten neue Entwicklungsmöglichkeiten für den Globalen Süden schaffen
Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026
Desktop versie